At a glance
- Originator Medivir AB
- Class Antivirals
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
Most Recent Events
- 02 Feb 2001 Profile reviewed but no significant changes made
- 13 Mar 1995 No-Development-Reported for HIV infections treatment in Sweden (Unknown route)